27.09.2017 • News

Azelis Buys Swiss Specialties Distributor

(c) Azelis
(c) Azelis

Azelis has acquired Georges Walther, a family-owned specialty chemicals distributor based in Pfäffikon, Switzerland, for an undisclosed sum.

Most of Georges Walther’s sales revenue is derived from cosmetic ingredients, essential oils and fragrances, where the company has developed particular expertise in spheres, beads and soft pearls. Its portfolio also includes pharmaceutical ingredients, food supplements and food ingredients. The company employs nine people and operates a warehouse in Rümlang, Zurich.

“Combining this acquisition with existing operations from Azelis Switzerland and Azelis Germany will give us the perfect platform to strengthen our presence in the Swiss market,” said Anna Bertona, Azelis CEO & president, Europe, Middle East & Africa (EMEA).

Georges Walther’s CEO, Jean-Michel Walther, said the deal gives access to Azelis’ application labs, technical services and network, allowing it to continue on a growth path. Walther will take on a new role within Azelis as business manager for personal care in Switzerland.

The deal, which is Azelis’ fourth acquisition this year, is expected to close during the course of the coming months.

In January, Azelis added US distributor Ross Organic, followed by Denmark’s LCH in June and Chemcolour in Australia and New Zealand in July.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.